Which practices should be maintained or what changes to the Task Force governance or structure could further support transparency, accountability, independence and leadership, towards rigorous, timely, agile and inclusive guidelines?
Considering the broader preventive health care landscape, what should be the mandate of the Task Force of the future and how can it collaborate with other entities involved in guideline development nationally and internationally?
How can the Task Force strengthen interest holder engagement including with subject-matter experts, equity-deserving communities and other groups to address health equity disparities and reflect Canadian diversity in guideline development and implementation?